Article History
Accepted: 20 May 2021
First Online: 16 July 2021
Declarations
:
: Bryden Considine declares that he has no conflict of interest. Adebowale Adeniran declares that he has no conflict of interest. Michael E. Hurwitz has received funding for clinical trials from Achilles Therapeutics, Apexigen, Arrowhead Pharmaceuticals, Astellas, AstraZeneca, Bayer, Bristol-Myers Squibb, CRISPR Therapeutics, Corvus Pharmaceuticals, Eli Lilly, Endocyte, Genentech, Genmab, GlaxoSmithKline, Innocrin Pharmaceuticals, Iovance Biotherapeutics, KSQ Therapeutics, Merck, Nektar Therapeutics, Novartis, Pfizer, Progenics, Sanofi Aventis, Seattle Genetics, Tmunity Therapeutics, Torque Therapeutics, and Unum Therapeutics; has received compensation from Bristol-Myers Squibb, CRISPR Therapeutics, Exelixis, Merck, and Nektar Therapeutics for participation on advisory boards; and his spouse has received honoraria from Arvinas and Gamida Cell Ltd.